Latest Breaking News On - Assessment of spondyloarthritis international society - Page 1 : comparemela.com

High NSAID Use for axSpA May Not Raise Risk for Hypertension

There was no difference in the risk for hypertension between patients with axial spondylarthritis who were high and low NSAID users, according to new data.

United statesBoston universityJose meade aguilarSpondyloarthritis researchBoston university school of medicineTreatment networkAssessment of spondyloarthritis international societySpondyloarthritis international societyBoston university school

One-Year Data Back Upadacitinib for Clinical Spondyloarthritis

One-Year Data Back Upadacitinib for Clinical Spondyloarthritis
medpagetoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medpagetoday.com Daily Mail and Mail on Sunday newspapers.

John geverAssessment of spondyloarthritis international societyHealth indexSpondyloarthritis international societyAxial spondyloarthritis disease activity scoreBath ankylosing spondylitis functional indexManaging editor

Bimekizumab Shows Sustained Efficacy in Treating Axial Spondyloarthritis for 52 Weeks

Results from a study presented at the Academy of Managed Care Pharmacy 2024 annual meeting demonstrated sustained efficacy of bimekizumab compared with placebo in patients with non-radiographic and radiographic axial spondyloarthritis (axSpA) at week 52.

Assessment of spondyloarthritis international societySpondyloarthritis international societyPublished april

Clinical Challenges: Diagnosing Axial Spondyloarthritis

Diagnosis remains difficult because of the high rates of chronic back pain from other causes

United statesHospital for special surgeryNew yorkLiron caplanNancy walshDalit ashanyWeill cornell medical collegeUniversity of coloradoOregon health science university in portlandRegina collegeSpondyloarthritis researchAssessment of spondyloarthritis international societySpondylitis association of americaAmerican college of rheumatologyTreatment networkSpecial surgery

Bimekizumab sustains axial spondyloarthritis improvements at 52 weeks

Bimekizumab sustains axial spondyloarthritis improvements at 52 weeks
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Shenaz baghaXenofon baraliakosByjustin cooperAssessment of spondyloarthritis international societyRuhr university bochumSpondyloarthritis international society